©2010 Baishideng.
World J Gastroenterol. Aug 21, 2010; 16(31): 3888-3896
Published online Aug 21, 2010. doi: 10.3748/wjg.v16.i31.3888
Published online Aug 21, 2010. doi: 10.3748/wjg.v16.i31.3888
Table 5 Past and current additional medication of 173 inflammatory bowel diseases patients included in the association analysis
| Additional medication | n |
| 5-Aminosalicylic acid | 142 |
| 6-Mercaptopurine | 33 |
| Adalimumab | 3 |
| Antibiotics | 64 |
| Azathioprine | 122 |
| Bisphosphonates | 8 |
| Certulizumab | 1 |
| Cholestyramine | 8 |
| Cyclosporine | 8 |
| Infliximab | 45 |
| Methotrexate | 27 |
| Sulfasalazine | 12 |
| Ursodeoxycholic acid | 3 |
- Citation: Mwinyi J, Wenger C, Eloranta JJ, Kullak-Ublick GA. Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients. World J Gastroenterol 2010; 16(31): 3888-3896
- URL: https://www.wjgnet.com/1007-9327/full/v16/i31/3888.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i31.3888